All Other Therapeutic Products (All Other Therapeutic Products)


Combined with:

Lipitor
Lyrica
Neurontin

Indications and Reactions:

Role Indications Reactions
Secondary
Ill-defined Disorder 34.8%
Drug Use For Unknown Indication 17.8%
Oesophageal Carcinoma 7.0%
Pain 4.9%
Convulsion 4.1%
Depression 4.1%
Blood Cholesterol Increased 3.7%
Erectile Dysfunction 3.5%
Arthritis 2.7%
Insomnia 2.5%
Neuralgia 2.2%
Anxiety 1.8%
Glaucoma 1.6%
Headache 1.6%
Multiple Sclerosis 1.6%
Hyperlipidaemia 1.4%
Back Pain 1.2%
Diabetes Mellitus 1.2%
Hypertension 1.2%
Pneumonia 1.2%
Suicide Attempt 27.7%
Respiratory Arrest 9.4%
Treatment Noncompliance 6.9%
Vomiting 6.3%
Weight Decreased 6.3%
Weight Increased 5.7%
Tremor 4.4%
Completed Suicide 3.8%
Unevaluable Event 3.8%
Somnolence 3.1%
Myocardial Infarction 2.5%
Pulmonary Embolism 2.5%
Stomach Discomfort 2.5%
Vision Blurred 2.5%
Weight Loss Poor 2.5%
Wrong Drug Administered 2.5%
Drug Toxicity 1.9%
Nausea 1.9%
Pain 1.9%
Rash 1.9%
Concomitant
Ill-defined Disorder 23.7%
Drug Use For Unknown Indication 7.9%
Pain 7.8%
Neuralgia 7.7%
Blood Cholesterol Increased 6.7%
Erectile Dysfunction 5.1%
Diabetic Neuropathy 4.6%
Neuropathy 4.2%
Hypertension 4.0%
Arthritis 3.9%
Depression 3.6%
Neuropathy Peripheral 3.0%
Convulsion 2.9%
Back Pain 2.6%
Post Herpetic Neuralgia 2.2%
Blood Cholesterol 2.1%
Epilepsy 2.1%
Glaucoma 2.1%
Oesophageal Carcinoma 2.1%
Hypersensitivity 1.8%
Weight Increased 13.4%
Weight Decreased 10.2%
Vomiting 9.7%
Somnolence 9.4%
Vision Blurred 7.1%
Myocardial Infarction 5.4%
Visual Disturbance 5.1%
Drug Ineffective 4.8%
Tremor 4.0%
Pain 3.7%
Myalgia 3.4%
Rash 3.4%
Treatment Noncompliance 3.4%
Hypertension 3.1%
Oedema Peripheral 2.8%
Dizziness 2.3%
Pain In Extremity 2.3%
Syncope 2.3%
Visual Acuity Reduced 2.3%
Cerebrovascular Accident 2.0%

Drug Data